Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply
Europace
.
2022 Apr 5;24(4):698-699.
doi: 10.1093/europace/euac013.
Authors
Andrea Mazzanti
1
2
3
,
Alessandro Trancuccio
1
2
3
,
Deni Kukavica
1
2
3
,
Eleonora Pagan
4
,
Meng Wang
5
,
Muhammed Mohsin
1
,
Derick Peterson
5
,
Vincenzo Bagnardi
4
,
Wojciech Zareba
6
,
Silvia G Priori
1
2
3
Affiliations
1
Molecular Cardiology, Istituti Clinici Scientifici Maugeri, IRCCS, Via Maugeri, 10, Pavia 27100, Italy.
2
Department of Molecular Medicine, University of Pavia, Pavia, Italy.
3
Molecular Cardiology, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.
4
Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Milan, Italy.
5
Department of Computational Biology and Biostatistics, University of Rochester, Rochester, NY, USA.
6
Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, 265 Crittenden Blvd., CU 420653, NY 14642, USA.
PMID:
35303087
DOI:
10.1093/europace/euac013
No abstract available
Publication types
Editorial
Comment
MeSH terms
Death, Sudden, Cardiac
Humans
Long QT Syndrome* / diagnosis
Long QT Syndrome* / genetics
Grants and funding
Italian Ministry of Health and Italian Ministry of Research and University Dipartimenti di Eccellenza 2018-2022